Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biotage AB (publ)
  6. Summary
    BIOT   SE0000454746

BIOTAGE AB (PUBL)

(BIOT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
244.2(c) 245(c) 256.6(c) 263.6(c) 268.2(c) Last
40 705 32 270 90 183 73 070 35 963 Volume
+1.67% +0.33% +4.73% +2.73% +1.75% Change
More quotes
Estimated financial data (e)
Sales 2021 1 203 M 140 M 140 M
Net income 2021 215 M 25,0 M 25,0 M
Net cash position 2021 303 M 35,3 M 35,3 M
P/E ratio 2021 79,6x
Yield 2021 0,65%
Sales 2022 1 370 M 160 M 160 M
Net income 2022 237 M 27,6 M 27,6 M
Net cash position 2022 390 M 45,4 M 45,4 M
P/E ratio 2022 76,2x
Yield 2022 0,71%
Capitalization 17 487 M 2 038 M 2 039 M
EV / Sales 2021 14,3x
EV / Sales 2022 12,5x
Nbr of Employees 469
Free-Float 100%
More Financials
Company
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical... 
More about the company
Ratings of Biotage AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about BIOTAGE AB (PUBL)
10/20BIOTAGE : acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synt..
AQ
10/20BIOTAGE AB (OM : BIOT) acquired ATDBio Ltd for ?45 million.
CI
08/16BIOTAGE : Opens New Facility To Produce COVID-19 Vaccine Material
MT
08/16BIOTAGE : New capacity helps eliminate bottleneck for COVID-19 vaccines
AQ
07/16BIOTAGE () : Interim report January – June 2021
PU
07/16BIOTAGE AB : (publ) Interim report January - June 2021
AQ
07/16Biotage AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/16TRANCHE UPDATE ON BIOTAGE AB (OM : BIOT)'s Equity Buyback Plan announced on August 18, 202..
CI
07/01Biotage AB Appoints Maja Nilsson as Member of Group Management
CI
07/01BIOTAGE AB : (publ) appoints new CFO
AQ
07/01Biotage AB Appoints Maja Nilsson as CFO, Effective from October 1, 2021
CI
06/29BIOTAGE : Berenberg Bank is now covering Biotage AB (publ) (BIOT)
AQ
06/21BIOTAGE : Launches New Automated Platform for Plasmid DNA Purification
AQ
06/21Biotage Announces the Launch of Biotage® Phyprep
CI
05/10BIOTAGE : CFO To Leave
MT
More news
News in other languages on BIOTAGE AB (PUBL)
06/29AVIS D'ANALYSTES DU JOUR : Danone, Nestlé, Thales, Vivendi, Sanlorenzo, Burberry, Lonza, F..
More news
Chart BIOTAGE AB (PUBL)
Duration : Period :
Biotage AB (publ) Technical Analysis Chart | BIOT | SE0000454746 | MarketScreener
Technical analysis trends BIOTAGE AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 268,20 SEK
Average target price 237,50 SEK
Spread / Average Target -11,4%
EPS Revisions
Managers and Directors
Tomas Blomquist President & Chief Executive Officer
Maja Nilsson Chief Financial Officer
Torben Vedel Stahl Jörgensen Chairman
Jon-Sverre Schanche Chief Scientific Officer
Magnus Nordstedt Executive Vice President-IT & Digitalization
Sector and Competitors
1st jan.Capi. (M$)
BIOTAGE AB (PUBL)92.95%2 038
SARTORIUS AG68.99%45 569
REVENIO GROUP OYJ15.51%1 795
CELLAVISION AB (PUBL)45.47%1 242
VAREX IMAGING CORPORATION61.09%1 060
908 DEVICES INC.-39.05%960